Robert Hsu

Dr. Robert Hsu is an Assistant Professor of Medicine in the Division of Medical Oncology at University of Southern California focusing on thoracic cancers. Dr. Hsu completed his medical school training at Tulane University School of Medicine followed by Internal Medicine residency training at University of Miami/Jackson Memorial and then hematology and oncology training at Los Angeles County+University of Southern California where he served as chief fellow for medical oncology.

His research interests are focused in lung cancer research along with cancer disparities across multiple solid tumor types. His research includes projects involving comprehensive genomic profiling looking at biomarkers in lung cancer, retrospective database work looking at lung cancer patients treated at USC looking at mutation differences among different ethnicities particularly Hispanics, epidemiological research looking at lung and thyroid cancer incorporating the California Cancer Registry, and translational research looking at tumor microenvironment and ethnicities in lung and breast cancer.

• National Institutes of Health: NIH Summer Student Intramural Award, 2007
• Cornell University: Cornell University Community Partnership Grant, 2008
• Cornell University: Cum Laude Distinction, 2009
• AmeriCorps: AmeriCorps Segal Education Award, 2010
   – 2011
• Tulane University School of Medicine: Southern Section-American Federation for Clinical Research Travel Award, 2014
• Asian Pacific American Medical Student President’s Award for Distinguished Service, 2017
• Summit on National and Global Cancer Health Disparities Travel Award, 2018
• University of Southern California: Best Research Award at USC Medical Oncology Fellows Research Symposium, 2021
   – 2022
• International Association for the Study of Lung Cancer: Academy Award, 2024

• Cornell University, Ithaca, NY — BS — 2009 — Biological Sciences & Biometry & Statistics
• University of Toledo, Toledo, OH — MS — 2012 — Biomedical Sciences
• Tulane University School of Medicine, New Orleans, LA — MD — 2016
• University of Miami/Jackson Memorial Hospital, Miami, FL — 2019 — Residency, Internal Medicine
• University of Southern California, Los Angeles, CA — 2022 — Fellowship, Hematology & Oncology

• A phase II study of subcutaneous atezolizumab in NSCLC patients using a decentralized clinical trial model
  Robert A. Winn Excellence in Clinical Trials Career Development Award · Oct 1, 2024 – Jan 1, 2027

• Cancer Disparities
• Cancer Tumor Microenvironment/Immunotherapy
• Lung Cancer
• Hispanic and Asian Pacific Islander Health

• Daneshmand, Siamak
• Kim, Anthony
• Lenz, Heinz-Josef
• Djaladat, Hooman
• Nieva, Jorge
• Gill, Inderbir